TGFB1 and cancer: Furthermore, inhibiting DAPK1 enhances cancer stem cell (CSC) stemness and the epithelial-mesenchymal transition (EMT) process, with the DAPK1-ZEB1 axis potentially intersecting the TGF-β and WNT pathways and influencing both CSCs and EMT processes [34].